LivaNova PLC LIA.F Stock
LivaNova PLC Price Chart
LivaNova PLC LIA.F Financial and Trading Overview
LivaNova PLC stock price | 54 EUR |
Previous Close | 41.6 EUR |
Open | 42.8 EUR |
Bid | 42.8 EUR x N/A |
Ask | 44.4 EUR x N/A |
Day's Range | 42.8 - 42.8 EUR |
52 Week Range | 37.6 - 53.5 EUR |
Volume | 100 EUR |
Avg. Volume | 3 EUR |
Market Cap | 2.41B EUR |
Beta (5Y Monthly) | 0.825 |
PE Ratio (TTM) | 856 |
EPS (TTM) | -0.55 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
LIA.F Valuation Measures
Enterprise Value | 2.63B EUR |
Trailing P/E | 856 |
Forward P/E | 17.258064 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 2.1560688 |
Price/Book (mrq) | 1.8810706 |
Enterprise Value/Revenue | 2.35 |
Enterprise Value/EBITDA | 23.251 |
Trading Information
LivaNova PLC Stock Price History
Beta (5Y Monthly) | 0.825 |
52-Week Change | N/A |
S&P500 52-Week Change | N/A |
52 Week High | 53.5 EUR |
52 Week Low | 37.6 EUR |
50-Day Moving Average | 43.77 EUR |
200-Day Moving Average | 44.9 EUR |
LIA.F Share Statistics
Avg. Volume (3 month) | 3 EUR |
Avg. Daily Volume (10-Days) | 20 EUR |
Shares Outstanding | 53.87M |
Float | 53.63M |
Short Ratio | N/A |
% Held by Insiders | 0.49% |
% Held by Institutions | 103.97% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | September 30, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0.25% |
Operating Margin (ttm) | 1.55% |
Gross Margin | 67.43% |
EBITDA Margin | 10.10% |
Management Effectiveness
Return on Assets (ttm) | 1.74% |
Return on Equity (ttm) | 0.24% |
Income Statement
Revenue (ttm) | 1.12B EUR |
Revenue Per Share (ttm) | 20.81 EUR |
Quarterly Revenue Growth (yoy) | 13.30% |
Gross Profit (ttm) | 696.73M EUR |
EBITDA | 113.03M EUR |
Net Income Avi to Common (ttm) | 2.87M EUR |
Diluted EPS (ttm) | 0.05 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 233.94M EUR |
Total Cash Per Share (mrq) | 4.34 EUR |
Total Debt (mrq) | 620.94M EUR |
Total Debt/Equity (mrq) | 50.67 EUR |
Current Ratio (mrq) | 3.229 |
Book Value Per Share (mrq) | 22.753 |
Cash Flow Statement
Operating Cash Flow (ttm) | 39.66M EUR |
Levered Free Cash Flow (ttm) | 3.97M EUR |
Profile of LivaNova PLC
Country | Germany |
State | N/A |
City | London |
Address | 20 Eastbourne Terrace |
ZIP | W2 6LG |
Phone | 44 20 3325 0660 |
Website | https://www.livanova.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 2900 |
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. It also engages in research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.
Q&A For LivaNova PLC Stock
What is a current LIA.F stock price?
LivaNova PLC LIA.F stock price today per share is 54 EUR.
How to purchase LivaNova PLC stock?
You can buy LIA.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for LivaNova PLC?
The stock symbol or ticker of LivaNova PLC is LIA.F.
Which industry does the LivaNova PLC company belong to?
The LivaNova PLC industry is Medical Devices.
How many shares does LivaNova PLC have in circulation?
The max supply of LivaNova PLC shares is 55.1M.
What is LivaNova PLC Price to Earnings Ratio (PE Ratio)?
LivaNova PLC PE Ratio is now.
What was LivaNova PLC earnings per share over the trailing 12 months (TTM)?
LivaNova PLC EPS is -0.55 EUR over the trailing 12 months.
Which sector does the LivaNova PLC company belong to?
The LivaNova PLC sector is Healthcare.